Literature DB >> 12113119

Can cure be achieved in patients with head and neck carcinomas? The problem of second neoplasm.

X León1, M Quer, C Orús, M del Prado Venegas.   

Abstract

The improvement in locoregional control of head and neck carcinomas over the last few decades does not appear to modify the final survival of these patients, mainly due to the appearance of distant metastases and second neoplasms. This article reviews the topic of second neoplasm in patients with an index tumor in the head and neck, making a special point of the incidence and epidemiology of second neoplasms, the influence on prognosis, etiopathogenic theories and the possibility of prevention.

Entities:  

Mesh：

Year:  2001        PMID： 12113119     DOI： 10.1586/14737140.1.1.125

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


  9 in total

1.  Optical imaging predicts tumor response to anti-EGFR therapy.

Authors:  Emily E Helman; J Robert Newman; Nichole R Dean; Wenyue Zhang; Kurt R Zinn; Eben L Rosenthal
Journal:  Cancer Biol Ther       Date:  2010-07-15       Impact factor: 4.742

Review 2.  European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer.

Authors:  Ricard Simo; Patrick Bradley; Dominique Chevalier; Frederik Dikkers; Hans Eckel; Nayla Matar; Giorgio Peretti; Cesare Piazza; Mark Remacle; Miquel Quer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-09       Impact factor: 2.503

3.  Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.

Authors:  Nichole R Dean; J Robert Newman; Emily E Helman; Wenyue Zhang; Seena Safavy; D M Weeks; Mark Cunningham; Linda A Snyder; Yi Tang; Li Yan; Lacey R McNally; Donald J Buchsbaum; Eben L Rosenthal
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

4.  Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules.

Authors:  Ram Prasad; Santosh K Katiyar
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

5.  Grape seed proanthocyanidins inhibit the invasiveness of human HNSCC cells by targeting EGFR and reversing the epithelial-to-mesenchymal transition.

Authors:  Qian Sun; Ram Prasad; Eben Rosenthal; Santosh K Katiyar
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

6.  Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition.

Authors:  Qian Sun; Ram Prasad; Eben Rosenthal; Santosh K Katiyar
Journal:  BMC Complement Altern Med       Date:  2011-12-21       Impact factor: 3.659

7.  Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.

Authors:  Tripti Singh; Nirzari A Gupta; Su Xu; Ram Prasad; Sadanandan E Velu; Santosh K Katiyar
Journal:  Oncotarget       Date:  2015-08-28

8.  Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.

Authors:  Oisín Bugter; Dirk L P van Iwaarden; Emilie A C Dronkers; Martine J de Herdt; Marjan H Wieringa; Gerda M Verduijn; Marc A M Mureau; Ivo Ten Hove; Esther van Meerten; José A Hardillo; Robert J Baatenburg de Jong
Journal:  Head Neck       Date:  2019-01-16       Impact factor: 3.147

9.  Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes.

Authors:  Xi Luo; Xiaodong Huang; Shaoyan Liu; Xiaolei Wang; Jingwei Luo; Jianping Xiao; Kai Wang; Yuan Qu; Xuesong Chen; Ye Zhang; Jingbo Wang; Jianghu Zhang; Guozhen Xu; Li Gao; Runye Wu; Junlin Yi
Journal:  Cancer Med       Date:  2022-01-26       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.